Bavarian Nordic A/S buy melinda
Start price
17.08.24
/
20%
€41.01
Target price
17.08.25
-
Performance (%)
-10.53%
End price
31.08.24
€36.69
Summary
This prediction ended on 31.08.24 with a price of €36.69. The price of Bavarian Nordic A/S has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.53%. melinda has 20% into this predictionBavarian Nordic (symbol: BAVA) is a biotechnology company that specializes in developing innovative vaccines for serious diseases such as cancer and infectious diseases like Ebola and COVID-19. The company has a broad portfolio of vaccines that are under development and has collaboration agreements with various pharmaceutical companies and government agencies. Bavarian Nordic's flagship product is its cancer vaccine known as PROSTVAC, which is currently undergoing clinical trials for the treatment of prostate cancer. The company is listed on the NASDAQ Copenhagen stock exchange and has a market capitalization of approximately $925 million as of May 2021.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Bavarian Nordic A/S | -5.293% |
| iShares Core DAX® | -0.372% |
| iShares Nasdaq 100 | -1.950% |
| iShares Nikkei 225® | -1.690% |
| iShares S&P 500 | -0.399% |
Comments by melinda for this prediction
In the thread Bavarian Nordic A/S diskutieren
Buy Bavarian Nordic A/S
In the thread Trading Bavarian Nordic A/S
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by melinda for Bavarian Nordic A/S
Bavarian Nordic A/S
Start price
Target price
Perf. (%)
€48.38
19.08.22
19.08.22
€51.00
19.08.23
19.08.23
-60.85%
20.08.23
20.08.23
Bavarian Nordic A/S
Start price
Target price
Perf. (%)
€33.34
19.09.17
19.09.17
€50.00
27.12.17
27.12.17
-8.84%
27.12.17
27.12.17
Bavarian Nordic A/S
Start price
Target price
Perf. (%)
€33.34
19.09.17
19.09.17
€50.00
27.12.17
27.12.17
-8.84%
27.12.17
27.12.17